# Real-world Study of Acalabrutinib

> **NCT06767891** · — · ENROLLING_BY_INVITATION · sponsor: **Ruijin Hospital** · enrollment: 200 (estimated)

## Conditions studied

- MCL
- CLL

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06767891
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-02
- **Primary completion:** 2026-07-30
- **Final completion:** 2028-01-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06767891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06767891, "Real-world Study of Acalabrutinib". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06767891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*